Comment on: A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

By Sathi Navtej   Gladston-Chelliah Easwardhas   Chattopadhyay Chandrabushan  

British Journal of Rheumatology , Vol. 52, Iss. 4, 2013-04 ,pp. : 761-761

Oxford University Press

Access to resources Recommend Favorite

Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial

By Kavanaugh Arthur   Menter Alan   Mendelsohn Alan   Shen Yaung-Kaung   Lee Seina   Gottlieb Alice B.  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2385-2392

Informa Healthcare

Access to resources Recommend Favorite

Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 12, 2015-12 ,pp. : 1739-1749

John Wiley & Sons Inc

Access to resources Recommend Favorite

Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis

By Greenwald M.   Peloso P.M.   Mandel D.   Soto O.   Frontera N.   Boice J.A.   Zhan X.J.   Curtis S.P.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 2033-2042

Informa Healthcare

Access to resources Recommend Favorite

Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2570-2579

John Wiley & Sons Inc

Access to resources Recommend Favorite